944.F BIOMAXIMA SA ZY 1

Healthcare Biotechnology Frankfurt Exchange
1.65 EUR
Close of Nov 11, 2026
1.64 3.35
Market cap
EUR 6.93M
P/E
33.0x
P/B
0.63x
ROE
2.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 944.F undervalued?

Graham number
Price1.65
Graham value1.72
Discount3.9%

944.F trades 3.9% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIOMAXIMA SA ZY 1 fundamental analysis

No fundamental analysis for BIOMAXIMA SA ZY 1 yet.

BIOMAXIMA SA ZY 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIOMAXIMA SA ZY 1

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which include real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibio…

Full company profile